Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Merigan

Showing results (61-70 of 366) with videos related to

Pageof 37
Sort By:
Viral Immunology|January 1, 1992
CD8+ CD11+ suppressor cells in HIV-infected asymptomatic patients: effect on HIV-specific cytotoxicityS K Kundu, T C Merigan
Antimicrobial Agents and Chemotherapy|July 14, 2001
Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nuleoside analogsM A Winters, T C Merigan
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1973
A useful quantitative semimicromethod for viral plaque assayB Rager-Zisman, T C Merigan
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1975
Mechanism of the suppressive effect of interferon on antibody synthesis in vivoB R Brodeur, T C Merigan
Nature|April 25, 1970
Synthetic polyanions protect mice against intracellular bacterial infectionJ S Remington, T C Merigan
Immunology|September 1, 1994
Relationship of HIV-1 provirus load, CD8+ CD11+ T cells and HIV-1 envelope-specific cytotoxic T lymphocytes in HIV-infected asymptomatic offientsS K Kundu, T C Merigan
Immunology|June 1, 1997
Heterogeneity of cytokine functions in HIV infectionS K Kundu, T C Merigan
Archives of Internal Medicine|January 1, 1980
Zoster immune globulin prophylaxis of disseminated zoster in compromised hosts. A randomized trialD A Stevens, T C Merigan
Journal of Acquired Immune Deficiency Syndromes|January 1, 1994
Human immunodeficiency virus envelope glycoproteinsT C Merigan, S K Kundu
The Journal of Infectious Diseases|May 1, 1986
Significance of local gamma interferon in recurrent herpes simplex infectionJ W Torseth, T C Merigan
Pageof 37

Showing results (61-70 of 366) with videos related to

Sort By:
Pageof 37
Viral Immunology|January 1, 1992
CD8+ CD11+ suppressor cells in HIV-infected asymptomatic patients: effect on HIV-specific cytotoxicityS K Kundu, T C Merigan
Antimicrobial Agents and Chemotherapy|July 14, 2001
Variants other than aspartic acid at codon 69 of the human immunodeficiency virus type 1 reverse transcriptase gene affect susceptibility to nuleoside analogsM A Winters, T C Merigan
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|April 1, 1973
A useful quantitative semimicromethod for viral plaque assayB Rager-Zisman, T C Merigan
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1975
Mechanism of the suppressive effect of interferon on antibody synthesis in vivoB R Brodeur, T C Merigan
Nature|April 25, 1970
Synthetic polyanions protect mice against intracellular bacterial infectionJ S Remington, T C Merigan
Immunology|September 1, 1994
Relationship of HIV-1 provirus load, CD8+ CD11+ T cells and HIV-1 envelope-specific cytotoxic T lymphocytes in HIV-infected asymptomatic offientsS K Kundu, T C Merigan
Immunology|June 1, 1997
Heterogeneity of cytokine functions in HIV infectionS K Kundu, T C Merigan
Archives of Internal Medicine|January 1, 1980
Zoster immune globulin prophylaxis of disseminated zoster in compromised hosts. A randomized trialD A Stevens, T C Merigan
Journal of Acquired Immune Deficiency Syndromes|January 1, 1994
Human immunodeficiency virus envelope glycoproteinsT C Merigan, S K Kundu
The Journal of Infectious Diseases|May 1, 1986
Significance of local gamma interferon in recurrent herpes simplex infectionJ W Torseth, T C Merigan
Pageof 37